Literature DB >> 9299631

Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome.

R Fearns1, M E Peeples, P L Collins.   

Abstract

A popular model for RNA synthesis by nonsegmented negative-strand RNA viruses is that transcription and RNA replication are executed by the same polymerase complex and that there is a dynamic balance between the two processes that is mediated by the nucleocapsid N protein. According to this model, transcription occurs until sufficient soluble N protein accumulates to initiate encapsidation of the nascent RNA product, which somehow switches the polymerase into a readthrough replicative mode. This model was examined for respiratory syncytial virus (RSV) using a reconstituted transcription and RNA replication system that involves a minireplicon and viral proteins that are expressed intracellularly from transfected plasmids. Preliminary experiments showed that reconstituted RNA replication was highly productive, such that on average each molecule of plasmid-supplied minigenome that became encapsidated was amplified 10- to 50-fold. N protein was increased on its own or in concert with the phosphoprotein P and in the presence or absence of the M2 ORF1 transcription elongation factor. The maximum level of N and P protein expression achieved from plasmids equalled or exceeded that obtained in RSV-infected cells. Increased levels of N protein stimulated RNA replication. This is consistent with the idea that RNA replication is dependent on the availability of N protein for encapsidation, which is one postulate of the model. The M2 ORF1 protein had no detectable effect on RNA replication under the various conditions of expression of N and P, which confirmed and extended previous results. However, there was no evidence of a significant switch in positive-sense RNA synthesis from transcription (synthesis of mRNAs) to RNA replication (synthesis of antigenome). The synthesis of positive-sense antigenome and mRNA appeared to occur at a fixed ratio, with mRNA being by far the more abundant product. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299631     DOI: 10.1006/viro.1997.8734

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  56 in total

1.  The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription.

Authors:  A Bermingham; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  A single amino acid substitution in the phosphoprotein of respiratory syncytial virus confers thermosensitivity in a reconstituted RNA polymerase system.

Authors:  A C Marriott; S D Wilson; J S Randhawa; A J Easton
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

3.  The major attenuating mutations of the respiratory syncytial virus vaccine candidate cpts530/1009 specify temperature-sensitive defects in transcription and replication and a non-temperature-sensitive alteration in mRNA termination.

Authors:  K Juhasz; B R Murphy; P L Collins
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  Structural phosphoprotein M2-1 of the human respiratory syncytial virus is an RNA binding protein.

Authors:  I Cuesta; X Geng; A Asenjo; N Villanueva
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  Ebolavirus polymerase uses an unconventional genome replication mechanism.

Authors:  Laure R Deflubé; Tessa N Cressey; Adam J Hume; Judith Olejnik; Elaine Haddock; Friederike Feldmann; Hideki Ebihara; Rachel Fearns; Elke Mühlberger
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-08       Impact factor: 11.205

6.  Mutations in the 5' trailer region of a respiratory syncytial virus minigenome which limit RNA replication to one step.

Authors:  M E Peeples; P L Collins
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimization.

Authors:  Cyril Le Nouën; Linda G Brock; Cindy Luongo; Thomas McCarty; Lijuan Yang; Masfique Mehedi; Eckard Wimmer; Steffen Mueller; Peter L Collins; Ursula J Buchholz; Joshua M DiNapoli
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

8.  Evidence that the respiratory syncytial virus polymerase is recruited to nucleotides 1 to 11 at the 3' end of the nucleocapsid and can scan to access internal signals.

Authors:  Vanessa M Cowton; Rachel Fearns
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 9.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

10.  Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles.

Authors:  M N Teng; P L Collins
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.